Overview

Type 2 Diabetes and the Effect of Probiotics

Status:
Unknown status
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Insulin-resistance in type 2 diabetes is associated with chronic inflammation. Anti-inflammatory actions might increase sensitivity to insulin. Since some probiotics have anti-inflammatory properties, ingestion of the probiotic bacteria Lactobacillus Acidophilus NCFM might increase insulin-sensitivity. The inflammatory response to endotoxin injection and the insulin-sensitivity is examined before and after four weeks ingestion of probiotics.
Phase:
N/A
Details
Lead Sponsor:
Rigshospitalet, Denmark
Collaborator:
Royal Veterinary and Agricultural University, Denmark